Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpe Special Opp Regulatory News (ESO)

Share Price Information for Epe Special Opp (ESO)

Share Price is delayed by 15 minutes
Get Live Data
237.00    0.00 (0.00%)
Bid:
232.00
Ask:
242.00
Spread: 10.00 (4.31%)
Market Cap: £58.41m
ESO Live PriceLast checked at - London Stock Exchange

Intraday Epe Special Opp Share Chart

Net Asset Value and Disposal

1 Oct 2018 07:00

RNS Number : 4309C
EPE Special Opportunities Limited
01 October 2018
 

EPE Special Opportunities Limited

Net Asset Value and Disposal

EPE Special Opportunities Limited ("ESO") announces that ESO Investments (PC) LLP ("ESO PC LLP"), a limited liability partnership in which it is the majority limited partner, has disposed of its investment in Process Components Limited ("PCL") to Schenck Process UK Limited.

 

Following the disposal of PCL, ESO's estimated Net Asset Value per share as at 30 September 2018 is 216.31 pence per share. This estimated Net Asset Value per share incorporates a 11.16 pence per share uplift generated by the disposal valuation of PCL.

 

The disposal returns £13.6 million in total to ESO PC LLP at the exit date as cash and a total of £18.2 million since the acquisition in March 2005 via income, loan repayments and the disposal proceeds. The total return to ESO PC LLP since March 2005 equates to a 4.5x Money Multiple and 20.7% IRR.

 

The disposal has a positive impact on ESO and was completed at a 44.1% premium to PCL's prevailing holding value of £9.5 million. ESO intends to use the capital returned for new deals.

 

The person responsible for releasing this information on behalf of the Company is Hilary Jones of R&H Fund Services (Jersey) Limited.

 

Enquiries:

 

EPIC Private Equity LLP

Alex Leslie

+44 (0) 20 7269 8865

 

 

R&H Fund Services (Jersey) Limited

Hilary Jones

+44 (0) 1534 825 323

 

 

Cardew Group

Richard Spiegelberg

+44 (0) 20 7930 0777

 

 

Numis Securities Ltd

+44 (0) 20 7260 1000

Nominated Advisor & Broker:

Stuart Skinner / Charles Farquhar / Huw Jeremy

 

 

 

Disclaimer: This valuation, which has been prepared in good faith by the Company's investment adviser, is for information purposes only. It is derived from unaudited estimated valuations of the Company's underlying investments based on information received by the investment adviser which may relate to dates or periods some time before the date of this valuation. Such estimates may be subject to little verification or other due diligence and may not comply with generally accepted accounting practices or other generally accepted valuation principles. If a valuation estimate subsequently proves to be incorrect, no adjustment is expected to be made to any previously published estimated net asset value.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCWGUCWBUPRGQU
Date   Source Headline
5th Jun 20265:20 pmRNSUpdate on Share Buy Backs
5th Jun 20267:00 amRNSNet Asset Value(s)
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20265:00 pmRNSHolding(s) in Company
1st Jun 20264:25 pmRNSTransaction in Own Shares
1st Jun 20267:00 amRNSAnnouncement of Share Buy Backs
29th May 20261:30 pmRNSDirector/PDMR Shareholding
27th May 20264:00 pmRNSPartial Sell Down of Investment in Luceco plc
8th May 20267:00 amRNSNet Asset Value(s)
28th Apr 20265:05 pmRNSHolding(s) in Company
28th Apr 20265:00 pmRNSDirector/PDMR Shareholding
28th Apr 20267:15 amRNSDirector/PDMR Shareholding
23rd Apr 20267:15 amRNSHolding(s) in Company
16th Apr 20262:50 pmRNSHolding(s) in Company
16th Apr 20262:45 pmRNSDirector/PDMR Shareholding
15th Apr 20269:12 amRNSNet Asset Value(s)
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSAnnual Financial Report
20th Feb 20266:22 pmRNSUpdate on Share Buy Backs
18th Feb 20261:00 pmRNSTransaction in Own Shares
17th Feb 20265:10 pmRNSHolding(s) in Company
17th Feb 20265:00 pmRNSHolding(s) in Company
17th Feb 20261:35 pmRNSTransaction in Own Shares
13th Feb 20267:00 amRNSAnnouncement of Share Buy Backs
9th Feb 20267:00 amRNSTrading Statement
4th Feb 20267:00 amRNSInterest Payment on Unsecured Loan Notes
15th Jan 20267:00 amRNSNet Asset Value(s)
22nd Dec 20257:00 amRNSUpdate on Share Buy Backs
22nd Dec 20257:00 amRNSUpdate on Share Buy Backs
11th Dec 20257:00 amRNSNet Asset Value(s)
4th Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:03 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:08 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSNet Asset Value(s)
13th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSHolding(s) in Company
17th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.